Growth trajectory Exosens group shows sustained revenue growth in H1 2026 and overall positive momentum, signaling an expanding addressable market for infrared imaging solutions and potential upsell opportunities across vSWIR, SWIR, and LWIR product lines.

Strategic expansion Recent acquisitions and partnerships, including Emberion acquisition and Gemesis partnership, indicate an active growth strategy to broaden detection technologies and modular industrial test systems, presenting cross-sell opportunities for Xenics imaging solutions within integrated platforms.

Key defense & industrial wins New contract with BROLIS to supply high-performance image intensifier tubes for armed forces highlights demand for advanced imaging and ruggedized solutions, suggesting potential sales avenues for Xenics in defense, safety, and security end-markets.

Financing momentum Significant financing facility with the EIB expands the group’s capacity for R&D and large-scale deployments, creating opportunities to position Xenics’ high-quality imaging systems in funded programs and large-scale industrial/commercial projects.

Global reach European vendor with worldwide sales and service network enables rapid deployment and localized support, making Xenics an attractive partner for multinational customers seeking consistent imaging performance and compliance across regions.